Literature DB >> 9409209

Does insulin resistance unite the separate components of the insulin resistance syndrome? Evidence from the Miami Community Health Study.

R P Donahue1, J A Bean, R D Donahue, R B Goldberg, R J Prineas.   

Abstract

A number of coronary heart disease risk factors have been identified that often cluster together to increase the risk of macrovascular disease. This cluster is referred to as the insulin resistance syndrome, and the risk factors commonly include dyslipidemia, elevated blood pressure, an android pattern of body fat distribution, and glucose intolerance. Whether hyperinsulinemia or insulin resistance per se provides a common pathway for these metabolic abnormalities is unclear. The authors studied 50 nondiabetic persons who had completed a euglycemic hyperinsulinemic clamp protocol in addition to a 75-g oral glucose tolerance test and other measures of the coronary risk profile. Using principal-component analysis, we reduced nine coronary risk factors to two uncorrelated factors that explained 54.5% of the variance. Factor 1 consisted of positive loadings for uric acid, systolic and diastolic blood pressure, triglyceride concentration, and waist girth and negative loadings for HDL cholesterol and the rate of insulin-mediated glucose disposal (M, in milligrams per kilogram of body weight per minute). M also loaded on factor 2, along with fasting insulin and glucose concentrations, diastolic blood pressure, and waist girth. The observation that M loaded on both factors suggests that a resistance to insulin action may provide the mechanism uniting the features of the insulin resistance syndrome. Hyperinsulinemia with concomitant insulin resistance may be necessary to produce this metabolic derangement, as well as the increased risk of macrovascular complications.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9409209     DOI: 10.1161/01.atv.17.11.2413

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  7 in total

1.  Impaired fasting glucose and recurrent cardiovascular disease among survivors of a first acute myocardial infarction: evidence of a sex difference? The Western New York experience.

Authors:  R P Donahue; J M Dorn; S Stranges; M Swanson; K Hovey; M Trevisan
Journal:  Nutr Metab Cardiovasc Dis       Date:  2010-03-15       Impact factor: 4.222

2.  Serum complement C3 has a stronger association with insulin resistance than high sensitive C-reactive protein in non-diabetic Chinese.

Authors:  Bangqiong Wang; Qifu Li; Yuanjuan Jiang; Zhoujun Liu; Li Zhong; Rong Luo; Qingfeng Cheng; Hua Qing
Journal:  Inflamm Res       Date:  2010-08-13       Impact factor: 4.575

3.  Adipocytokines as features of the metabolic syndrome determined using confirmatory factor analysis.

Authors:  Mark M Smits; Pier Woudstra; Kristina M Utzschneider; Jenny Tong; Fernando Gerchman; Mirjam Faulenbach; Darcy B Carr; Kathryn Aston-Mourney; Alan Chait; Robert H Knopp; James B Meigs; Edward J Boyko; Steven E Kahn
Journal:  Ann Epidemiol       Date:  2013-03-25       Impact factor: 3.797

4.  Risk factors for prehypertension in the community: a prospective analysis from the Western New York Health Study.

Authors:  R P Donahue; S Stranges; L Rafalson; J Dmochowski; J Dorn; M Trevisan
Journal:  Nutr Metab Cardiovasc Dis       Date:  2013-12-18       Impact factor: 4.222

Review 5.  What is the relationship between exercise and metabolic abnormalities? A review of the metabolic syndrome.

Authors:  Sean Carroll; Mike Dudfield
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

6.  Association of curry consumption with blood lipids and glucose levels.

Authors:  Youngjoo Kwon
Journal:  Nutr Res Pract       Date:  2016-01-28       Impact factor: 1.926

7.  Identification of biomarkers for type 2 diabetes and its complications: a bioinformatic approach.

Authors:  Srinubabu Gedela; Allam Appa Rao; Narasimha Rao Medicherla
Journal:  Int J Biomed Sci       Date:  2007-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.